S-Caineâ¢ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults
Information source: ZARS Pharma Inc.
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: S-Caineâ¢ Peel (lidocaine and tetracaine cream 7%/7%) (Drug)
Phase: Phase 3
Sponsored by: ZARS Pharma Inc.
There is pain associated with laser-assisted tattoo removal. For this reason, some form of
anesthesia is commonly used to eliminate or minimize the pain. This anesthesia is usually a
topical local anesthetic cream or ointment spread over the skin. The purpose of this study
is to further estimate the effectiveness of S-Caine™ Peel (lidocaine 7% and tetracaine 7%
cream) for treating pain during laser-assisted tattoo removal.
Official title: A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia for Laser-Assisted Tattoo Removal in Adults
Study design: Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Primary outcome: To evaluate the efficacy of S-Caine Peel when applied for 60 minutes for induction of local dermal anesthesia prior to laser-assisted tattoo removal in adults
Secondary outcome: To monitor the nature and frequency of adverse events (AEs) associated with the application of S-Caine Peel
Minimum age: 18 Years.
Maximum age: N/A.
Patient is 18 years of age or older
Patient elects to undergo laser-assisted tattoo removal
Patient is pregnant or breastfeeding
Patient has participated in a clinical trial of an unapproved drug within the previous 30
Patient has participated in any previous clinical trial involving S-Caine Peel
Locations and Contacts
Laser and Skin Surgery Center of New York, New York, New York 10016, United States
Ending date: September 2005
Last updated: September 21, 2005